Celesq® Programs

Association for Molecular Pathology v. Myriad Genetics, Inc.: The Supreme Court Declares Isolated DNA Unpatentable, from the Celesq®-West LegalEdcenter IP Master Series

In one of the most closely watched intellectual property decisions of the last several years, the Supreme Court held that isolated DNA does not represent patentable subject matter, but that synthetic DNA does. Anthony LoCicero of Amster, Rothstein and Ebenstein LLC (who participated as an amicus in Myriad) discusses the Myriad decision and its factual underpinnings, the relationship of this decision with prior Supreme Court precedents, and the implications both to the biotechnology industry and to other fields for which patentable subject matter issues are economically crucial.

Available in States

• Arizona
• California
• Colorado Eligible
• Georgia
• Missouri
• New Jersey Eligible
• New York
• Texas Self Study

Program Categories

• Corporate and Commercial Law
• Federal Courts
• In-House Counsel
• Intellectual Property Law
• Litigation & Litigation Skills
• Patent Law

PROGRAM CREDITS

• Areas of Professional Practice : 1 Credit
• 1.0 General CLE credit, based on a 60-minute credi : 1 Credit